De Novo Aortic Regurgitation After Continuous-Flow Left Ventricular Assist Device Implantation

Gašparović, Hrvoje; Kopjar, Tomislav; Saeed, Diyar; Čikeš, Maja; Svetina, Lucija; Petričević, Mate; Lovrić, Daniel; Miličić, Davor; Biočina, Bojan

doi:10.1016/j.athoracsur.2017.01.114

Cited by 35 publications

(32 citation statements)

References 35 publications

(85 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Factors that influenced AR development and progression were older age, persistent aortic valve closure, duration of LVAD support and female gender [456]. Treatment options include HTx, bioprosthetic valve replacement, patch closure or valve repairs.…”

Section: Aortic Insufficiency and Late Right Heart Failurementioning

confidence: 99%

See 1 more Smart Citation

2019 EACTS Expert Consensus on long-term mechanical circulatory support

Potapov

Antonides

Crespo-Leiro

et al. 2019

European Journal of Cardio-Thoracic Surgery

263

446

View full text Add to dashboard Cite

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for patients with severe heart failure. Different devices are available, and many—sometimes contradictory—observations regarding patient selection, surgical techniques, perioperative management and follow-up have been published. With the growing expertise in this field, the European Association for Cardio-Thoracic Surgery (EACTS) recognized a need for a structured multidisciplinary consensus about the approach to patients with LT-MCS. However, the evidence published so far is insufficient to allow for generation of meaningful guidelines complying with EACTS requirements. Instead, the EACTS presents an expert opinion in the LT-MCS field. This expert opinion addresses patient evaluation and preoperative optimization as well as management of cardiac and non-cardiac comorbidities. Further, extensive operative implantation techniques are summarized and evaluated by leading experts, depending on both patient characteristics and device selection. The faculty recognized that postoperative management is multidisciplinary and includes aspects of intensive care unit stay, rehabilitation, ambulatory care, myocardial recovery and end-of-life care and mirrored this fact in this paper. Additionally, the opinions of experts on diagnosis and management of adverse events including bleeding, cerebrovascular accidents and device malfunction are presented. In this expert consensus, the evidence for the complete management from patient selection to end-of-life care is carefully reviewed with the aim of guiding clinicians in optimizing management of patients considered for or supported by an LT-MCS device.

show abstract

Section: Aortic Insufficiency and Late Right Heart Failurementioning

confidence: 99%

“…Treatment options include HTx, bioprosthetic valve replacement, patch closure or valve repairs. Transcatheter procedures have been shown to be effective for patients in whom the risk of reoperation is prohibitive [456–461].…”

Section: Aortic Insufficiency and Late Right Heart Failurementioning

confidence: 99%

2019 EACTS Expert Consensus on long-term mechanical circulatory support

Potapov

Antonides

Crespo-Leiro

et al. 2019

European Journal of Cardio-Thoracic Surgery

263

446

View full text Add to dashboard Cite

show abstract

“…Факторы, способствующие развитию недостаточности клапана аорты и ее прогрессированию, -пожилой возраст, длительное время функционирования УДМЦПМ, а также женский пол [47]. Лечение заключается в трансплантации сердца, замене клапана биопротезом, закрытии заплатой или хирургической пластике клапана.…”

Section: недостаточность клапана аортыunclassified

Supporting Devices in the Treatment of Chronic Heart Failure in Elderly and Old Patients

et al. 2020

View full text Add to dashboard Cite

Chronic heart failure (CHF) is a widespread disease associated with high rates of disability and mortality, as well as a decrease in the quality of life. Moreover, the vast majority of patients are elderly and senile. Modern surgical methods of treating heart failure are able to increase the duration and quality of life of such patients, however, the need far exceeds the volume of this care, and some highly effective methods common in Western countries are still not used in Russian clinical practice. Elderly age is a risk factor for the development of senile asthenia (frailty) and concomitant pathology. Large abdominal surgery is often contraindicated for patients with signs of senile asthenia, and the method of choice in patients with severe heart failure is the implantation of devices for long-term mechanical circulatory support (LT-MCS). After implantation of LT-MCS, a regression of signs of senile asthenia may be observed. The topic of an integrated approach to non-drug treatment of heart failure in elderly and senile patients in Russia has not been studied enough. In particular, the implantation of LT-MCS is not used in Russian clinical practice, while in many Western countries for many years it has been the main and most effective treatment for severe heart failure. Systematization of the available up-to-date information on this topic could help increase the duration and quality of life of patients with severe heart failure.

show abstract

“…Aortic insufficiency (AI) is very common complication after continuous-flow left ventricular assist device (LVAD) implantation, and can result in increased symptoms for LVAD patients. [1][2][3] Recent advances in transcatheter aortic valve replacement (TAVR) technology has resulted in this becoming a potential therapeutic avenue for LVAD patients with AI. We report a case of TAVR implantation in a patient supported with an LVAD complicated by thrombosis.…”

Section: Introductionmentioning

confidence: 99%

Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device

Rao

Jagasia

Anwaruddin

et al. 2020

Cathet Cardio Intervent

View full text Add to dashboard Cite

Aortic insufficiency (AI) is a frequent problem after continuous-flow left ventricular assist device (LVAD) implantation and results in increased morbidity and mortality. Advances in transcatheter aortic valve replacement (TAVR) technology have resulted in this being discussed as a potential option for LVAD patients with AI. While small case series have been published, we report the first case of TAVR thrombosis in an LVAD patient. This case highlights a major diagnostic and management dilemma that should become more present if this strategy becomes more widespread.

show abstract

De Novo Aortic Regurgitation After Continuous-Flow Left Ventricular Assist Device Implantation

Cited by 35 publications

References 35 publications

2019 EACTS Expert Consensus on long-term mechanical circulatory support

2019 EACTS Expert Consensus on long-term mechanical circulatory support

Supporting Devices in the Treatment of Chronic Heart Failure in Elderly and Old Patients

Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device

Contact Info

Product

Resources

About